✨ Your Portfolio is fetched and updated from zerodha.
Micro Agriculture

Nath Bio-Genes (India) Ltd.

NATHBIOGEN

Market Cap
₹327 Cr.
P/E
7.68

Nath Bio-Genes (India) Ltd.

  • Nath Bio-Genes
  • JK Agri Genetics
  • Shree Oswal Seeds
FAQs on Nath Bio-Genes (India) Ltd. Shareprice

Nath Bio-Genes has given lower returns compared to its competitors.
Nath Bio-Genes has grown at ~-13.95% over the last 7yrs while peers have grown at a median rate of 8.78%

Nath Bio-Genes is not expensive.
Latest PE of Nath Bio-Genes is 7.68, while 3 year average PE is 7.95.
Also latest EV/EBITDA of Nath Bio-Genes is 7.0 while 3yr average is 10.78.

View FAQ's On Business
Growth Table
  • Nath Bio-Genes (India) Ltd.
  • JK Agri Genetics
  • Shree Oswal Seeds
Balance Sheet
  • Nath Bio-Genes (India) Ltd.
  • JK Agri Genetics
  • Shree Oswal Seeds
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Nath Bio-Genes (India) Ltd.
  • JK Agri Genetics
  • Shree Oswal Seeds
Cash Flow
  • Nath Bio-Genes (India) Ltd.
  • JK Agri Genetics
  • Shree Oswal Seeds
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Nath Bio-Genes (India) Ltd.
  • JK Agri Genetics
  • Shree Oswal Seeds
Quarterly Results
  • Nath Bio-Genes (India) Ltd.
  • JK Agri Genetics
  • Shree Oswal Seeds
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Nath Bio-Genes (India) Ltd. Financials

Balance sheet of Nath Bio-Genes is moderately strong, But short term working capital might become an issue for this company.

The debt of Nath Bio-Genes is decreasing.
Latest debt of Nath Bio-Genes is -₹55.21 Crs as of Mar-25.
This is less than Mar-24 when it was -₹44.45 Crs.

The profit is oscillating.
The profit of Nath Bio-Genes is ₹42.52 Crs for TTM, ₹38.6 Crs for Mar 2025 and ₹39.62 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Nath Bio-Genes latest dividend payout ratio is 9.85% and 3yr average dividend payout ratio is 10.1%

Companies resources are allocated to majorly unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech